Co-Diagnostics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Co-Diagnostics generated cash of -$22,081,865, which is less than the previous year. Cash used in financing activities reached the amount of -$1,363,929 last year. Net change in cash is therefore -$8,056,925.
Cash Flow
| 2015 | -1.53M | -110.27K | 1.46M |
|---|---|---|---|
| 2016 | -1.31M | -12.24K | 2.28M |
| 2017 | -3.21M | -189.30K | 5.93M |
| 2018 | -4.08M | -380.33K | 1.87M |
| 2019 | -5.52M | -435.24K | 5.90M |
| 2020 | 28.16M | -5.82M | 19.74M |
| 2021 | 41.08M | 4.09M | 450.39K |
| 2022 | 6.56M | -58.16M | -14.03M |
| 2023 | -22.08M | 15.38M | -1.36M |
CODX Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 22.97M | 88.60M | 42.97M | 893.13K | 950.23K | 3.53M | 998.73K | 33.80K | 214.44K |
Operating activities | |||||||||
Net income | -35.33M | -14.23M | 36.65M | 42.47M | -6.19M | -6.27M | -6.95M | -1.92M | -2.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 1.23M | 1.28M | 335.36K | 138.63K | 65.90K | 50.76K | 45.75K | 37.49K | 43.14K |
Stock-based compensation expense | 8.33M | 7.54M | 5.50M | 2.73M | 1.08M | 0 | 2.03M | 69.56K | 45.49K |
| Deferred income tax benefit | 8.33M | 7.54M | 5.50M | 2.73M | 1.08M | 0 | 2.03M | 69.56K | 45.49K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 2.53M | 14.95M | -8.74M | -12.96M | -121.46K | -13.42K | -698.38K | 0 | 0 |
Inventories | 413.14K | -3.52M | 5.70M | -7.91M | -179.01K | -9.08K | -9.06K | 0 | 0 |
Accounts payable | 1.76M | -2.48M | -299.93K | 3.75M | -226.66K | 85.94K | 8.37K | 0 | 385.56K |
Cash generated by operating activities | -22.08M | 6.56M | 41.08M | 28.16M | -5.52M | -4.08M | -3.21M | -1.31M | -1.53M |
Investing activities | |||||||||
Purchases Of Investments | -110.49M | -67.99M | -491.73K | -9.31M | -322K | 0 | -60K | 0 | 0 |
Investments In Property Plant And Equipment | -1.36M | -1.42M | -669.46K | -774.39K | -113.24K | -41.33K | -129.30K | -12.24K | -118.46K |
Acquisitions Net | 0 | 1.59K | 1.68M | -714.5K | -322K | -339K | 0 | 0 | 8.19K |
Cash generated by investing activities | 15.38M | -58.16M | 4.09M | -5.82M | -435.24K | -380.33K | -189.30K | -12.24K | -110.27K |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 25.16M | 19.74M | 5.49M | 0 | 7.07M | 0 | 470K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.36M | -14.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | -41.5K | -84.95K | 990K |
Cash used in financing activities | -1.36M | -14.03M | 450.39K | 19.74M | 5.90M | 1.87M | 5.93M | 2.28M | 1.46M |
Net Change In Cash | -8.05M | -65.63M | 45.63M | 42.08M | -57.09K | -2.58M | 2.53M | 964.93K | -180.64K |
Cash at end of period | 14.91M | 22.97M | 88.60M | 42.97M | 893.13K | 950.23K | 3.53M | 998.73K | 33.80K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |